Granisetron

4 trials 1 recruiting AGastroenterology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

2 Completed trials

3 Sponsors

6 Countries

Phase II

Phase IV

Phase II: 3 Phase IV: 1

Oversight events:

3 temporary halts 6 urgent safety measures across 2 trials

View oversight register →

Indications tested

Papillary serous endometrial carcinoma 1

Sponsors using this IMP

K-Group Beta Inc. 2 Fondazione Gimema Franco Mandelli Onlus 1 University Of Tartu 1

All trials

4 total

Effect on the tolerability of semaglutide in overweight adults without diabetes Pending

2025-524612-11-00 Phase IV 1 country University Of Tartu
Phase 2 Study of ZN‑c3 in High-Grade Serous Ovarian Cancer Recruiting

2022-502983-19-00 Phase II 5 countries K-Group Beta Inc.
Study to treat adult patients with Very High-Risk T-cell Acute Lymphoblastic Leukemia (ALL) with Daratumumab in addition to the National ALL… Ended

2024-511627-34-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma Ended

2023-507324-23-00 Phase II 3 countries K-Group Beta Inc.

Showing 1–4 of 4 trials

← All drugs A–Z